Taurolidine-Citrate Line Locks Prevent Recurrent Central Line Associated Bloodstream Infection in Pediatric Patients.
Pediatr Infect Dis J. 2018 Sep 10;:
Authors: Clark J, Graham N, Kleidon T, Ullman A
This study describes a successful, targeted intervention in central venous access device routine care, to decrease central line associated bloodstream infection (CLABSI). Taurolidine-Citrate locks significantly reduced the rate of CLABSI, particularly Gram negative organisms without adverse events.
PMID: 30204661 [PubMed - as supplied by publisher]